Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

12.5K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.5K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

7.6K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
7.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

15.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.2K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RYR:ATP6V0A1 complexes couple ER-lysosome contact sites to dynamic autophagy control.

Autophagy·2026
Same author

Anti-apoptotic BCL-2 binds to all three IP3R isoforms, thereby limiting the Ca2+-flux properties of IP3R homo-tetramers.

Open biology·2026
Same author

Patient-Derived 3D Bioprinted Cardiac Organoid Constructs Reveal Key Pathological Features of Duchenne Muscular Dystrophy.

Advanced healthcare materials·2026
Same author

Control of Inositol 1,4,5-Trisphosphate Receptor Activity by Posttranslational Modifications.

Cold Spring Harbor perspectives in biology·2026
Same author

Inactive ryanodine receptors sustain lysosomal availability for autophagy by promoting ER-lysosomal contact site formation.

Nature communications·2026
Same author

CISD2 ensures adequate ER-mitochondrial coupling, critically supporting mitochondrial function in neurons.

Acta neuropathologica communications·2025

Related Experiment Video

Updated: Apr 29, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

8.9K

Pharmacological and Biological Tools to Inhibit IP3 Receptors.

Robbe Van Gorp1, Tihomir Tomašič2, Jan B Parys1

  • 1Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.

Cold Spring Harbor Perspectives in Biology
|April 27, 2026
PubMed
Summary

Inositol 1,4,5-trisphosphate receptors (IP3Rs) are crucial ion channels controlling cell function. This review details IP3R antagonists, highlighting limitations in specificity and permeability for research and therapeutics.

More Related Videos

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

7.9K
Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

856

Related Experiment Videos

Last Updated: Apr 29, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

8.9K
Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

7.9K
Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

856

Area of Science:

  • Cellular Biology
  • Molecular Pharmacology
  • Biomedical Research

Background:

  • Inositol 1,4,5-trisphosphate receptors (IP3Rs) regulate calcium release, essential for cellular processes.
  • Dysfunctional IP3Rs are linked to various diseases, necessitating targeted inhibition.
  • Existing IP3R inhibitors lack specificity and membrane permeability, hindering research and therapy development.

Purpose of the Study:

  • To provide a comprehensive overview of IP3R-antagonizing tools.
  • To categorize IP3R antagonists based on their mechanisms of action.
  • To discuss limitations and potential of current IP3R inhibition strategies.

Main Methods:

  • Literature review of IP3R antagonists developed over decades.
  • Categorization of antagonists into pharmacological, biological, and upstream pathway regulators.
  • Analysis of selectivity, mechanism of action, and permeability of identified tools.

Main Results:

  • Identified three main classes of IP3R antagonists: direct pharmacological binders, direct biological interactors, and upstream pathway modulators.
  • Highlighted significant limitations in specificity and membrane permeability among current IP3R inhibitors.
  • Emphasized the need for more selective and cell-permeable IP3R antagonists.

Conclusions:

  • Development of highly specific IP3R antagonists is critical for advancing biomedical research.
  • Improved IP3R-targeting agents are needed to overcome limitations in current therapeutic strategies.
  • Further research into novel antagonism mechanisms is warranted for precise cellular control.